Long-term changes in pulmonary function among patients surviving to COVID-19 pneumonia.

Purpose: The aim of this study was to assess respiratory function at the time of clinical recovery, 6 weeks, 6 months, and 12 months after discharge in patients surviving to COVID-19 pneumonia.

Methods: Our case series consisted of 13 hospitalized patients with COVID-19 pneumonia.

Results: Baseline pulmonary function tests were 55.

Pulmonary function in patients surviving to COVID-19 pneumonia.

Purpose: The aim of our study was to assess respiratory function at the time of clinical recovery and 6 weeks after discharge in patients surviving to COVID-19 pneumonia.

Methods: Our case series consisted of 13 patients with COVID-19 pneumonia.

Results: At the time of clinical recovery, FEV1 (2.

A case of atrial tachycardia treated with ivabradine as bridge to ablation.

Ivabradine is indicated in cardiac failure and ischemia to reduce sinus rate by inhibition of the pacemaker I(f) current in sinoatrial node. We report a case of an 18-year-old woman with left atrial tachyarrhythmia resistant to several antiarrhythmic drugs and to electric cardioversion who responded only to ivabradine, which significantly reduced heart rate without abolishing the arrhythmia itself. An ectopic focus in the ostium of left pulmonary veins was found and the patient was successfully ablated.

Large pericardial effusion in a family with recurrent pericarditis: A report of probable x-linked transmission.

Three cases of recurrent pleuropericarditis were observed within the same family - in two sisters and their niece, who were 18, 35 and 18 years of age, respectively. One patient was treated with pericardiectomy, and the other two were treated with colchicine. Mutations associated with autoinflammatory diseases (tumour necrosis factor receptor-associated periodic syndrome and familial Mediterranean fever) were absent; the condition was found to be sex linked.